clear: lenvatinib and pembrolizumab efficacy in arcc across baseline tumor sizes
Published 6 months ago • 179 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
1:44
assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma
-
32:46
lenvatinib pembrolizumab in rcc, the clear trial with karine tawagi
-
2:32
len pembro metastatic clear cell renal cell carcinoma
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
7:05
health-related quality of life with lenvatinib plus pembrolizumab for patients with advanced rcc
-
4:44
vegfr inhibitors with immune checkpoint inhibitors for advanced renal cancer
-
5:14
lenvatinib plus pembrolizumab after progression on immune checkpoint inhibitors for metastatic rcc
-
4:27
lenvatinib in renal cell carcinoma
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
5:37
clear and navigating the frontline combination approaches for advanced rcc
-
5:00
keynote-b61: putting a focus on non-clear cell rcc treatment
-
0:50
dr. sznol discusses immunotherapy in non-clear cell renal cancer
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
1:17
treating non-clear cell renal cell carcinoma patients
-
4:28
metastatic renal cell carcinoma: lenvatinib phase ii data
-
6:52
nivolumab in renal cell carcinoma